

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.59105555 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59105555 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.22867374 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.22867374 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.82348730 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.18537112 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.18537112 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.18537112 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.03864054 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.01937896 |
| 11 | * bile acid biosynthetic process (GO:0006699) | 5.81063551 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.80625985 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.72829169 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 5.57208971 |
| 15 | urea cycle (GO:0000050) | 5.54385714 |
| 16 | urea metabolic process (GO:0019627) | 5.54385714 |
| 17 | complement activation, alternative pathway (GO:0006957) | 5.44964698 |
| 18 | glycosphingolipid catabolic process (GO:0046479) | 5.42932342 |
| 19 | regulation of protein activation cascade (GO:2000257) | 5.34833720 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.34308186 |
| 21 | oligosaccharide catabolic process (GO:0009313) | 5.31892455 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.30128573 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.28012117 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.25519322 |
| 25 | protein carboxylation (GO:0018214) | 5.25519322 |
| 26 | cysteine metabolic process (GO:0006534) | 5.22414441 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.19606878 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.11356110 |
| 29 | regulation of complement activation (GO:0030449) | 5.02239364 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00409087 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.95284604 |
| 32 | * bile acid metabolic process (GO:0008206) | 4.93606429 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.92813816 |
| 34 | glycolipid catabolic process (GO:0019377) | 4.91196859 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.80066317 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.79297046 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.74573678 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.63789997 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.61543858 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.59492978 |
| 41 | lysine metabolic process (GO:0006553) | 4.58108762 |
| 42 | lysine catabolic process (GO:0006554) | 4.58108762 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.54179652 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.54179652 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.54179652 |
| 46 | coenzyme catabolic process (GO:0009109) | 4.53034447 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.52178990 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.52178990 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.46933222 |
| 50 | indolalkylamine metabolic process (GO:0006586) | 4.36231579 |
| 51 | phospholipid efflux (GO:0033700) | 4.35898798 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.35810124 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.35810124 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.34555049 |
| 55 | ceramide catabolic process (GO:0046514) | 4.33421260 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 4.32765889 |
| 57 | amine catabolic process (GO:0009310) | 4.32765889 |
| 58 | epoxygenase P450 pathway (GO:0019373) | 4.27917142 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.26732240 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.26255083 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.23209463 |
| 62 | glycine metabolic process (GO:0006544) | 4.21846586 |
| 63 | cellular glucuronidation (GO:0052695) | 4.20309231 |
| 64 | ethanol oxidation (GO:0006069) | 4.19843160 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.19457233 |
| 66 | glutamate metabolic process (GO:0006536) | 4.17854272 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 4.09497829 |
| 68 | cholesterol efflux (GO:0033344) | 4.08741941 |
| 69 | serine family amino acid metabolic process (GO:0009069) | 4.06652815 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 4.06348489 |
| 71 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.00590931 |
| 72 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98982239 |
| 73 | amino sugar catabolic process (GO:0046348) | 3.97955947 |
| 74 | aldehyde catabolic process (GO:0046185) | 3.93674101 |
| 75 | arginine metabolic process (GO:0006525) | 3.90841271 |
| 76 | fibrinolysis (GO:0042730) | 3.89648703 |
| 77 | regulation of cholesterol storage (GO:0010885) | 3.88133178 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 3.87577891 |
| 79 | acetyl-CoA metabolic process (GO:0006084) | 3.87180167 |
| 80 | protein-lipid complex assembly (GO:0065005) | 3.86676049 |
| 81 | cofactor catabolic process (GO:0051187) | 3.86042179 |
| 82 | drug catabolic process (GO:0042737) | 3.84151561 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83035309 |
| 84 | complement activation, classical pathway (GO:0006958) | 3.82919818 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 3.82436701 |
| 86 | omega-hydroxylase P450 pathway (GO:0097267) | 3.81932657 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79234179 |
| 88 | cytolysis (GO:0019835) | 3.78768066 |
| 89 | complement activation (GO:0006956) | 3.77765052 |
| 90 | uronic acid metabolic process (GO:0006063) | 3.74003706 |
| 91 | glucuronate metabolic process (GO:0019585) | 3.74003706 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.73228112 |
| 93 | organic acid catabolic process (GO:0016054) | 3.73228112 |
| 94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72119865 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72119865 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 3.71624074 |
| 97 | protein activation cascade (GO:0072376) | 3.70650984 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.70574573 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.70222549 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68842086 |
| 101 | ketone body metabolic process (GO:1902224) | 3.68442182 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.67594706 |
| 103 | plasma lipoprotein particle organization (GO:0071827) | 3.65747634 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.65279894 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.64800849 |
| 106 | sterol homeostasis (GO:0055092) | 3.63877510 |
| 107 | regulation of cholesterol homeostasis (GO:2000188) | 3.62943560 |
| 108 | protein-lipid complex subunit organization (GO:0071825) | 3.56525593 |
| 109 | response to thyroid hormone (GO:0097066) | 3.54410065 |
| 110 | NAD biosynthetic process (GO:0009435) | 3.52077777 |
| 111 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.51236977 |
| 112 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.51236977 |
| 113 | opsonization (GO:0008228) | 3.50646487 |
| 114 | regulation of mononuclear cell migration (GO:0071675) | 3.41827251 |
| 115 | detection of molecule of bacterial origin (GO:0032490) | 3.33891908 |
| 116 | N-acetylneuraminate metabolic process (GO:0006054) | 3.33834808 |
| 117 | membrane lipid catabolic process (GO:0046466) | 3.30437031 |
| 118 | regulation of macrophage chemotaxis (GO:0010758) | 3.28575980 |
| 119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.28051922 |
| 120 | sphingolipid catabolic process (GO:0030149) | 3.25154893 |
| 121 | positive regulation of cholesterol efflux (GO:0010875) | 3.22547555 |
| 122 | regulation of apoptotic cell clearance (GO:2000425) | 3.20877945 |
| 123 | acute-phase response (GO:0006953) | 3.19082376 |
| 124 | negative regulation of interleukin-12 production (GO:0032695) | 3.13847818 |
| 125 | peptide catabolic process (GO:0043171) | 3.12565372 |
| 126 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.09986658 |
| 127 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.05930041 |
| 128 | exogenous drug catabolic process (GO:0042738) | 3.05214559 |
| 129 | lipoprotein metabolic process (GO:0042157) | 3.03563495 |
| 130 | detection of external biotic stimulus (GO:0098581) | 3.01358679 |
| 131 | detection of other organism (GO:0098543) | 3.01142335 |
| 132 | angiotensin maturation (GO:0002003) | 3.00574226 |
| 133 | positive regulation of extracellular matrix organization (GO:1903055) | 2.98422076 |
| 134 | response to peptidoglycan (GO:0032494) | 2.96905964 |
| 135 | positive regulation of sterol transport (GO:0032373) | 2.92236388 |
| 136 | positive regulation of cholesterol transport (GO:0032376) | 2.92236388 |
| 137 | neutrophil activation involved in immune response (GO:0002283) | 2.91548905 |
| 138 | regulation of superoxide anion generation (GO:0032928) | 2.90868002 |
| 139 | positive regulation of hemostasis (GO:1900048) | 2.88076950 |
| 140 | positive regulation of blood coagulation (GO:0030194) | 2.88076950 |
| 141 | positive regulation of coagulation (GO:0050820) | 2.87764373 |
| 142 | negative regulation of hemostasis (GO:1900047) | 2.84870439 |
| 143 | negative regulation of blood coagulation (GO:0030195) | 2.84870439 |
| 144 | fructose metabolic process (GO:0006000) | 2.83066956 |
| 145 | cholesterol transport (GO:0030301) | 2.77561529 |
| 146 | sterol transport (GO:0015918) | 2.77561529 |
| 147 | negative regulation of lipid transport (GO:0032369) | 2.74043611 |
| 148 | regulation of cholesterol transport (GO:0032374) | 2.74017235 |
| 149 | regulation of sterol transport (GO:0032371) | 2.74017235 |
| 150 | apoptotic cell clearance (GO:0043277) | 2.72477754 |
| 151 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.72454830 |
| 152 | lipoprotein transport (GO:0042953) | 2.71955076 |
| 153 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.71874149 |
| 154 | detection of bacterium (GO:0016045) | 2.70443947 |
| 155 | negative regulation of coagulation (GO:0050819) | 2.69667674 |
| 156 | positive regulation of leukocyte degranulation (GO:0043302) | 2.67881509 |
| 157 | macrophage activation involved in immune response (GO:0002281) | 2.67135204 |
| 158 | reactive oxygen species biosynthetic process (GO:1903409) | 2.65375641 |
| 159 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.62915013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.15644816 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.00101731 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.83926641 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.37081624 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.22627214 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88702329 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.88211335 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00844555 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.96884472 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.82857053 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.64964399 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.08331561 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95569968 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68519681 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11018014 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05763759 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00121751 |
| 18 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5388986 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98332049 |
| 20 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97830902 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.92181524 |
| 22 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.81515195 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74354250 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68663690 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62917057 |
| 26 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62598119 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62465801 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55421475 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55205371 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54469747 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53303182 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52943685 |
| 33 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51253824 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46091184 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.41568321 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39467817 |
| 37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36886332 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35889539 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34279922 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31222966 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28538951 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28428513 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28017116 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24261825 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22972718 |
| 46 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21078300 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19377243 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16821512 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16161595 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15955124 |
| 51 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15546106 |
| 52 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14857344 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14536762 |
| 54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13987570 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13945590 |
| 56 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13683875 |
| 57 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13143713 |
| 58 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.11899192 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09531224 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07293745 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06975181 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06792962 |
| 63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04598756 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03969242 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03784772 |
| 66 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00234063 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00093462 |
| 68 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99193412 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96961876 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96828224 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94924181 |
| 72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94106443 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94070798 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93836446 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93775302 |
| 76 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93254739 |
| 77 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92459205 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90889976 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90200389 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89051919 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88315473 |
| 82 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.87346393 |
| 83 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87019415 |
| 84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.85182035 |
| 85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84896488 |
| 86 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84366825 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83382039 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 0.83309454 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82191849 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81683101 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81557875 |
| 92 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81478515 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81277787 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81263805 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80699304 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80440577 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77444940 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76706122 |
| 99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76445504 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76445504 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76327904 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75111450 |
| 103 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.74852119 |
| 104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73600331 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72786267 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72255763 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71830740 |
| 108 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70912902 |
| 109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70249034 |
| 110 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66150767 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65080200 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61464851 |
| 113 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61344431 |
| 114 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60376924 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59985578 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59351151 |
| 117 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58514194 |
| 118 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57505588 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.56772328 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56375713 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53467592 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52846994 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52794910 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.52470024 |
| 125 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52406281 |
| 126 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.51974210 |
| 127 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51710759 |
| 128 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50981838 |
| 129 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.50899883 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50139599 |
| 131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50111172 |
| 132 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48322776 |
| 133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47165478 |
| 134 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47128885 |
| 135 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.46858267 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46536033 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45973085 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45909031 |
| 139 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44932114 |
| 140 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44600473 |
| 141 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44411667 |
| 142 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43455849 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.43391142 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42263864 |
| 145 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41215017 |
| 146 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40220457 |
| 147 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.39916967 |
| 148 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.39900557 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39598358 |
| 150 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39441201 |
| 151 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.38012771 |
| 152 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37725251 |
| 153 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37162519 |
| 154 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.37028646 |
| 155 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36843194 |
| 156 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.36722682 |
| 157 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.36214004 |
| 158 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35900131 |
| 159 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35637842 |
| 160 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.35611170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.15923398 |
| 2 | MP0005360_urolithiasis | 7.46300529 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.13286203 |
| 4 | MP0005365_abnormal_bile_salt | 6.07835246 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11276553 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.26861501 |
| 7 | MP0003252_abnormal_bile_duct | 3.94168459 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.53530410 |
| 9 | MP0009840_abnormal_foam_cell | 3.33988929 |
| 10 | MP0003172_abnormal_lysosome_physiology | 3.30046566 |
| 11 | MP0005083_abnormal_biliary_tract | 2.95879047 |
| 12 | MP0003195_calcinosis | 2.85691147 |
| 13 | MP0005332_abnormal_amino_acid | 2.77713074 |
| 14 | MP0003303_peritoneal_inflammation | 2.68332013 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.63748894 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.36728384 |
| 17 | MP0002419_abnormal_innate_immunity | 2.18667213 |
| 18 | MP0000609_abnormal_liver_physiology | 2.16349135 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.12537238 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.03830967 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.90519990 |
| 22 | MP0009785_altered_susceptibility_to | 1.88906712 |
| 23 | MP0003868_abnormal_feces_composition | 1.87224770 |
| 24 | * MP0004019_abnormal_vitamin_homeostasis | 1.85162581 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.83311402 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.74804386 |
| 27 | MP0005025_abnormal_response_to | 1.71610231 |
| 28 | MP0000343_altered_response_to | 1.67609036 |
| 29 | MP0001764_abnormal_homeostasis | 1.63409820 |
| 30 | MP0005387_immune_system_phenotype | 1.62861724 |
| 31 | MP0001790_abnormal_immune_system | 1.62861724 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61864508 |
| 33 | MP0002998_abnormal_bone_remodeling | 1.58836137 |
| 34 | MP0005257_abnormal_intraocular_pressure | 1.57160576 |
| 35 | MP0005451_abnormal_body_composition | 1.49749368 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.46202976 |
| 37 | MP0009697_abnormal_copulation | 1.44186473 |
| 38 | MP0000685_abnormal_immune_system | 1.43397209 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.37864436 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.37716525 |
| 41 | MP0003011_delayed_dark_adaptation | 1.36898245 |
| 42 | MP0005671_abnormal_response_to | 1.35775627 |
| 43 | MP0000920_abnormal_myelination | 1.32178773 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.31246023 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.28725921 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.28551487 |
| 47 | MP0003186_abnormal_redox_activity | 1.28088495 |
| 48 | MP0008260_abnormal_autophagy | 1.27281242 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.27067841 |
| 50 | MP0004510_myositis | 1.25977336 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.19599040 |
| 52 | MP0000598_abnormal_liver_morphology | 1.16160064 |
| 53 | MP0005647_abnormal_sex_gland | 1.14322949 |
| 54 | MP0000604_amyloidosis | 1.14171576 |
| 55 | MP0002723_abnormal_immune_serum | 1.13374748 |
| 56 | MP0000371_diluted_coat_color | 1.13080303 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.12105532 |
| 58 | MP0002254_reproductive_system_inflammat | 1.11196666 |
| 59 | MP0009764_decreased_sensitivity_to | 1.08451773 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.06313498 |
| 61 | MP0005310_abnormal_salivary_gland | 1.05255051 |
| 62 | MP0005670_abnormal_white_adipose | 1.05079158 |
| 63 | MP0001800_abnormal_humoral_immune | 1.02634685 |
| 64 | MP0009763_increased_sensitivity_to | 1.02406120 |
| 65 | MP0005164_abnormal_response_to | 1.01052852 |
| 66 | MP0000858_altered_metastatic_potential | 1.00515023 |
| 67 | MP0003879_abnormal_hair_cell | 0.99602962 |
| 68 | MP0002405_respiratory_system_inflammati | 0.98094109 |
| 69 | MP0002420_abnormal_adaptive_immunity | 0.95552008 |
| 70 | MP0001819_abnormal_immune_cell | 0.94748833 |
| 71 | MP0010368_abnormal_lymphatic_system | 0.92843624 |
| 72 | MP0008469_abnormal_protein_level | 0.92704947 |
| 73 | MP0004947_skin_inflammation | 0.92435536 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.90262903 |
| 75 | MP0006054_spinal_hemorrhage | 0.88626809 |
| 76 | MP0003690_abnormal_glial_cell | 0.86336563 |
| 77 | MP0003828_pulmonary_edema | 0.86166290 |
| 78 | MP0003632_abnormal_nervous_system | 0.85954382 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 0.85906576 |
| 80 | * MP0009642_abnormal_blood_homeostasis | 0.85468609 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 0.85385652 |
| 82 | MP0004130_abnormal_muscle_cell | 0.85228578 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 0.84492821 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.84492821 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.84209951 |
| 86 | MP0002971_abnormal_brown_adipose | 0.82993312 |
| 87 | MP0003448_altered_tumor_morphology | 0.82196665 |
| 88 | MP0005408_hypopigmentation | 0.81135929 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.80618494 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.78923842 |
| 91 | MP0002132_abnormal_respiratory_system | 0.78031610 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.78015234 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.76445845 |
| 94 | MP0005334_abnormal_fat_pad | 0.73569976 |
| 95 | MP0005535_abnormal_body_temperature | 0.72305927 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.72210439 |
| 97 | MP0003329_amyloid_beta_deposits | 0.71761983 |
| 98 | MP0003634_abnormal_glial_cell | 0.69020653 |
| 99 | MP0001661_extended_life_span | 0.67458686 |
| 100 | MP0005220_abnormal_exocrine_pancreas | 0.66917372 |
| 101 | MP0005266_abnormal_metabolism | 0.66274698 |
| 102 | MP0009278_abnormal_bone_marrow | 0.65642595 |
| 103 | MP0001915_intracranial_hemorrhage | 0.63480995 |
| 104 | MP0003633_abnormal_nervous_system | 0.61256966 |
| 105 | MP0001756_abnormal_urination | 0.58926240 |
| 106 | MP0001851_eye_inflammation | 0.58876136 |
| 107 | MP0003795_abnormal_bone_structure | 0.58408839 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.56534478 |
| 109 | MP0000716_abnormal_immune_system | 0.56194269 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.55887227 |
| 111 | MP0005448_abnormal_energy_balance | 0.54759696 |
| 112 | MP0005464_abnormal_platelet_physiology | 0.54207327 |
| 113 | MP0002837_dystrophic_cardiac_calcinosis | 0.53955035 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.53610283 |
| 115 | MP0004381_abnormal_hair_follicle | 0.51785699 |
| 116 | MP0003724_increased_susceptibility_to | 0.50445242 |
| 117 | MP0009053_abnormal_anal_canal | 0.50291063 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.49135664 |
| 119 | MP0003436_decreased_susceptibility_to | 0.47898391 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.47773806 |
| 121 | MP0003075_altered_response_to | 0.47305739 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.46741767 |
| 123 | MP0006082_CNS_inflammation | 0.46570740 |
| 124 | MP0008874_decreased_physiological_sensi | 0.46203006 |
| 125 | MP0008873_increased_physiological_sensi | 0.45807570 |
| 126 | MP0000579_abnormal_nail_morphology | 0.44552986 |
| 127 | MP0005395_other_phenotype | 0.44351108 |
| 128 | MP0005166_decreased_susceptibility_to | 0.43961658 |
| 129 | MP0002822_catalepsy | 0.43718225 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.43009186 |
| 131 | MP0002928_abnormal_bile_duct | 0.42819322 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.38240304 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.37625386 |
| 134 | MP0003953_abnormal_hormone_level | 0.37378340 |
| 135 | MP0003718_maternal_effect | 0.37082992 |
| 136 | MP0002796_impaired_skin_barrier | 0.36611213 |
| 137 | MP0009115_abnormal_fat_cell | 0.35722806 |
| 138 | MP0001853_heart_inflammation | 0.35621949 |
| 139 | MP0000249_abnormal_blood_vessel | 0.34879036 |
| 140 | MP0001243_abnormal_dermal_layer | 0.33790265 |
| 141 | MP0008872_abnormal_physiological_respon | 0.33301008 |
| 142 | MP0009672_abnormal_birth_weight | 0.32946337 |
| 143 | MP0002168_other_aberrant_phenotype | 0.31331826 |
| 144 | MP0002970_abnormal_white_adipose | 0.31019866 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.30592885 |
| 146 | MP0002090_abnormal_vision | 0.30375796 |
| 147 | MP0002060_abnormal_skin_morphology | 0.29774971 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.29657108 |
| 149 | MP0001881_abnormal_mammary_gland | 0.27271905 |
| 150 | MP0004883_abnormal_blood_vessel | 0.26128226 |
| 151 | MP0003453_abnormal_keratinocyte_physiol | 0.25654922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 7.63606224 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.63606224 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.63606224 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 7.36518259 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.36395140 |
| 6 | Deep venous thrombosis (HP:0002625) | 7.23082735 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.55164045 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 6.45601368 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 6.20466230 |
| 10 | * Xanthomatosis (HP:0000991) | 5.87287343 |
| 11 | Complement deficiency (HP:0004431) | 5.69375003 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.57636875 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 5.00809557 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.76113930 |
| 15 | Joint hemorrhage (HP:0005261) | 4.68393265 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.67879893 |
| 17 | Hyperammonemia (HP:0001987) | 4.61212394 |
| 18 | Hyperglycinemia (HP:0002154) | 4.39098996 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.34722892 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.32527906 |
| 21 | Abnormality of macrophages (HP:0004311) | 4.30152966 |
| 22 | Eczematoid dermatitis (HP:0000976) | 4.26087829 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 4.26033038 |
| 24 | Ketosis (HP:0001946) | 4.25049296 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23186463 |
| 26 | Abnormality of complement system (HP:0005339) | 4.17407447 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15716278 |
| 28 | Fat malabsorption (HP:0002630) | 4.15456013 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 4.14103316 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13180562 |
| 31 | Dysostosis multiplex (HP:0000943) | 4.12308234 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99368775 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.99368775 |
| 34 | Hyperglycinuria (HP:0003108) | 3.96250942 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.89372828 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.74456224 |
| 37 | Neurofibrillary tangles (HP:0002185) | 3.71963742 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71355917 |
| 39 | * Epidermoid cyst (HP:0200040) | 3.71109607 |
| 40 | Loss of speech (HP:0002371) | 3.70765822 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.69316356 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.67497909 |
| 43 | Purpura (HP:0000979) | 3.62260624 |
| 44 | Hypercholesterolemia (HP:0003124) | 3.59528049 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.56102558 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.56102558 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.56102558 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.50727209 |
| 49 | Mucopolysacchariduria (HP:0008155) | 3.50727209 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.47010703 |
| 51 | Recurrent abscess formation (HP:0002722) | 3.43907323 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42323244 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 3.32630047 |
| 54 | Hyperbilirubinemia (HP:0002904) | 3.28119363 |
| 55 | Disinhibition (HP:0000734) | 3.23927697 |
| 56 | Steatorrhea (HP:0002570) | 3.18848237 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 3.06306265 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 3.05068045 |
| 59 | Delayed CNS myelination (HP:0002188) | 3.05062682 |
| 60 | Ketoacidosis (HP:0001993) | 3.02360815 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01603067 |
| 62 | Spontaneous abortion (HP:0005268) | 2.96837396 |
| 63 | Hepatocellular carcinoma (HP:0001402) | 2.92486425 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.77916519 |
| 65 | Metabolic acidosis (HP:0001942) | 2.76613777 |
| 66 | Cerebral inclusion bodies (HP:0100314) | 2.72946028 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.68655646 |
| 68 | Vascular calcification (HP:0004934) | 2.63700469 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62528859 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.62528859 |
| 71 | Axonal loss (HP:0003447) | 2.60615499 |
| 72 | Mutism (HP:0002300) | 2.60516566 |
| 73 | Retinal atrophy (HP:0001105) | 2.60184505 |
| 74 | Lethargy (HP:0001254) | 2.58342318 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58124501 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 2.54744572 |
| 77 | Glomerulonephritis (HP:0000099) | 2.52928042 |
| 78 | Increased serum ferritin (HP:0003281) | 2.51065446 |
| 79 | Acanthocytosis (HP:0001927) | 2.50788197 |
| 80 | Mitral stenosis (HP:0001718) | 2.48508160 |
| 81 | Amyloidosis (HP:0011034) | 2.45583969 |
| 82 | Orchitis (HP:0100796) | 2.45215704 |
| 83 | Gout (HP:0001997) | 2.44199619 |
| 84 | Cerebral edema (HP:0002181) | 2.41193123 |
| 85 | Cholecystitis (HP:0001082) | 2.40047806 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.40047806 |
| 87 | Spastic diplegia (HP:0001264) | 2.38414116 |
| 88 | Irritability (HP:0000737) | 2.36825081 |
| 89 | Autoimmune thrombocytopenia (HP:0001973) | 2.36240180 |
| 90 | Hypoglycemic seizures (HP:0002173) | 2.34472009 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.33668977 |
| 92 | Neonatal onset (HP:0003623) | 2.32731253 |
| 93 | Metaphyseal irregularity (HP:0003025) | 2.26823703 |
| 94 | Gingivitis (HP:0000230) | 2.26357163 |
| 95 | * Myocardial infarction (HP:0001658) | 2.25573196 |
| 96 | Optic neuritis (HP:0100653) | 2.24911015 |
| 97 | Retrobulbar optic neuritis (HP:0100654) | 2.24911015 |
| 98 | Neuronal loss in central nervous system (HP:0002529) | 2.24768385 |
| 99 | Malnutrition (HP:0004395) | 2.23207177 |
| 100 | Myositis (HP:0100614) | 2.23051927 |
| 101 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.22612590 |
| 102 | Obstructive lung disease (HP:0006536) | 2.22606180 |
| 103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22606180 |
| 104 | Gingival bleeding (HP:0000225) | 2.22341203 |
| 105 | Nuclear cataract (HP:0100018) | 2.21478946 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20791412 |
| 107 | Diminished motivation (HP:0000745) | 2.19190763 |
| 108 | Apathy (HP:0000741) | 2.19071472 |
| 109 | * Skin nodule (HP:0200036) | 2.17017250 |
| 110 | Esophageal varix (HP:0002040) | 2.16997735 |
| 111 | Asymmetric septal hypertrophy (HP:0001670) | 2.16850107 |
| 112 | Peripheral demyelination (HP:0011096) | 2.16547552 |
| 113 | Pathologic fracture (HP:0002756) | 2.16213034 |
| 114 | Hepatosplenomegaly (HP:0001433) | 2.15864677 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 2.15761895 |
| 116 | * Abnormal gallbladder morphology (HP:0012437) | 2.14908435 |
| 117 | Pancreatitis (HP:0001733) | 2.14146281 |
| 118 | Brushfield spots (HP:0001088) | 2.12402629 |
| 119 | Progressive neurologic deterioration (HP:0002344) | 2.10404657 |
| 120 | Enlarged kidneys (HP:0000105) | 2.08857730 |
| 121 | Vomiting (HP:0002013) | 2.08651802 |
| 122 | Late onset (HP:0003584) | 2.07672340 |
| 123 | Hemorrhage of the eye (HP:0011885) | 2.06598551 |
| 124 | Thrombophlebitis (HP:0004418) | 2.05596960 |
| 125 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.05533051 |
| 126 | Upper motor neuron abnormality (HP:0002127) | 2.05201781 |
| 127 | Generalized aminoaciduria (HP:0002909) | 2.03473347 |
| 128 | Opisthotonus (HP:0002179) | 2.03399271 |
| 129 | * Cholelithiasis (HP:0001081) | 2.01890233 |
| 130 | Menorrhagia (HP:0000132) | 2.01623594 |
| 131 | Increased CSF protein (HP:0002922) | 2.00803324 |
| 132 | Rickets (HP:0002748) | 1.97324691 |
| 133 | Hypophosphatemic rickets (HP:0004912) | 1.96720474 |
| 134 | Protuberant abdomen (HP:0001538) | 1.96346915 |
| 135 | Abnormality of iron homeostasis (HP:0011031) | 1.94089598 |
| 136 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93432874 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.93185455 |
| 138 | Hydroxyprolinuria (HP:0003080) | 1.92795283 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 1.92795283 |
| 140 | Poikilocytosis (HP:0004447) | 1.92086645 |
| 141 | Recurrent skin infections (HP:0001581) | 1.91804689 |
| 142 | Vertebral compression fractures (HP:0002953) | 1.90333963 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89538627 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87450358 |
| 145 | Abnormal cartilage morphology (HP:0002763) | 1.84928052 |
| 146 | Alkalosis (HP:0001948) | 1.84685614 |
| 147 | Elevated hepatic transaminases (HP:0002910) | 1.84661532 |
| 148 | Bone pain (HP:0002653) | 1.84313550 |
| 149 | Nephritis (HP:0000123) | 1.82452374 |
| 150 | Renal cortical cysts (HP:0000803) | 1.79385172 |
| 151 | Pulmonary infiltrates (HP:0002113) | 1.78193323 |
| 152 | Hypophosphatemia (HP:0002148) | 1.77400495 |
| 153 | Cardiomegaly (HP:0001640) | 1.77397776 |
| 154 | * Dementia (HP:0000726) | 1.76711909 |
| 155 | Abnormality of vitamin metabolism (HP:0100508) | 1.76710557 |
| 156 | Nausea (HP:0002018) | 1.76481753 |
| 157 | * Abnormality of the gallbladder (HP:0005264) | 1.76446622 |
| 158 | J-shaped sella turcica (HP:0002680) | 1.74412900 |
| 159 | Acute hepatic failure (HP:0006554) | 1.71726081 |
| 160 | Thoracic kyphosis (HP:0002942) | 1.70829869 |
| 161 | Pulmonary embolism (HP:0002204) | 1.70444284 |
| 162 | Global brain atrophy (HP:0002283) | 1.69427550 |
| 163 | Abnormality of the lumbar spine (HP:0100712) | 1.68366547 |
| 164 | Gangrene (HP:0100758) | 1.63416119 |
| 165 | Supranuclear gaze palsy (HP:0000605) | 1.62389296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.67320908 |
| 2 | FGFR4 | 4.41109290 |
| 3 | ERN1 | 4.25001585 |
| 4 | SIK1 | 4.24634586 |
| 5 | TAOK3 | 3.06804369 |
| 6 | BLK | 3.06356086 |
| 7 | ERBB4 | 2.95774152 |
| 8 | ACVR1B | 2.89131261 |
| 9 | RIPK4 | 2.82022719 |
| 10 | INSRR | 2.78182386 |
| 11 | DDR2 | 2.31849049 |
| 12 | PDK2 | 2.28410843 |
| 13 | MST1R | 2.11059573 |
| 14 | GRK7 | 2.08897532 |
| 15 | FGR | 2.08799629 |
| 16 | MAP2K4 | 2.07560424 |
| 17 | PRPF4B | 1.98091023 |
| 18 | TYK2 | 1.93086532 |
| 19 | MAPK11 | 1.89851862 |
| 20 | PKN2 | 1.88822563 |
| 21 | FLT3 | 1.86325300 |
| 22 | NME2 | 1.83339608 |
| 23 | MATK | 1.75241925 |
| 24 | PIK3CG | 1.75080560 |
| 25 | EPHB1 | 1.70443569 |
| 26 | TRIB3 | 1.68300759 |
| 27 | LATS1 | 1.61452691 |
| 28 | FGFR2 | 1.60035823 |
| 29 | ZAP70 | 1.58793277 |
| 30 | PTK6 | 1.46227139 |
| 31 | NEK9 | 1.45639418 |
| 32 | TAOK2 | 1.39127431 |
| 33 | IRAK4 | 1.38710885 |
| 34 | ABL2 | 1.36843201 |
| 35 | CDC42BPA | 1.35260263 |
| 36 | PRKAA2 | 1.29783131 |
| 37 | MAP3K1 | 1.28674016 |
| 38 | JAK2 | 1.27819621 |
| 39 | DAPK2 | 1.27755603 |
| 40 | TBK1 | 1.27391077 |
| 41 | MAP3K14 | 1.27202060 |
| 42 | MAP3K7 | 1.26779522 |
| 43 | PINK1 | 1.21655489 |
| 44 | JAK1 | 1.18114161 |
| 45 | FRK | 1.14230632 |
| 46 | MAP2K3 | 1.12278288 |
| 47 | MAPK15 | 1.12208618 |
| 48 | MET | 1.12100998 |
| 49 | KDR | 1.09860750 |
| 50 | TAOK1 | 1.09610712 |
| 51 | TESK2 | 1.05973325 |
| 52 | ERBB2 | 1.02051672 |
| 53 | PKN1 | 1.00562874 |
| 54 | MAP3K2 | 0.97802346 |
| 55 | IRAK3 | 0.96979797 |
| 56 | MAPK4 | 0.95897219 |
| 57 | GRK6 | 0.95294872 |
| 58 | TTN | 0.90546987 |
| 59 | CAMKK2 | 0.88055273 |
| 60 | JAK3 | 0.87791458 |
| 61 | CAMK1D | 0.87634033 |
| 62 | MAPK12 | 0.87410807 |
| 63 | KSR2 | 0.85347047 |
| 64 | LYN | 0.84865051 |
| 65 | PRKCZ | 0.84827601 |
| 66 | MOS | 0.83889618 |
| 67 | MARK3 | 0.83878122 |
| 68 | SYK | 0.82398215 |
| 69 | CAMK2G | 0.81869498 |
| 70 | GSK3A | 0.80861133 |
| 71 | CSK | 0.80610753 |
| 72 | EPHA3 | 0.79723708 |
| 73 | MAP3K3 | 0.79526019 |
| 74 | CSF1R | 0.79399619 |
| 75 | FES | 0.78921895 |
| 76 | RPS6KA2 | 0.78488490 |
| 77 | HCK | 0.78212304 |
| 78 | TGFBR2 | 0.77593687 |
| 79 | TIE1 | 0.77504024 |
| 80 | PRKG2 | 0.75811914 |
| 81 | MAP3K10 | 0.75561125 |
| 82 | PDGFRA | 0.74029815 |
| 83 | PRKACG | 0.73054112 |
| 84 | STK38L | 0.69394770 |
| 85 | PRKAA1 | 0.68905961 |
| 86 | IKBKE | 0.67667612 |
| 87 | MAP3K13 | 0.67359198 |
| 88 | DYRK1B | 0.66630370 |
| 89 | PDPK1 | 0.65753412 |
| 90 | TESK1 | 0.65604382 |
| 91 | CDK6 | 0.64740872 |
| 92 | LCK | 0.64624243 |
| 93 | RPS6KC1 | 0.64450955 |
| 94 | RPS6KL1 | 0.64450955 |
| 95 | MAP2K6 | 0.63423398 |
| 96 | BMPR2 | 0.62672721 |
| 97 | RIPK1 | 0.61748290 |
| 98 | PAK4 | 0.61648608 |
| 99 | PRKCQ | 0.61294494 |
| 100 | SGK3 | 0.60190119 |
| 101 | TYRO3 | 0.59102041 |
| 102 | MAPK7 | 0.57481381 |
| 103 | ARAF | 0.56756151 |
| 104 | CSNK1G1 | 0.56215782 |
| 105 | FGFR3 | 0.55734216 |
| 106 | MAP3K11 | 0.54284588 |
| 107 | ADRBK2 | 0.52956069 |
| 108 | OBSCN | 0.52720290 |
| 109 | PBK | 0.50185998 |
| 110 | GRK1 | 0.49912124 |
| 111 | SGK494 | 0.49454753 |
| 112 | SGK223 | 0.49454753 |
| 113 | PTK2 | 0.49435445 |
| 114 | FYN | 0.48528713 |
| 115 | CAMK1G | 0.48340182 |
| 116 | TNK2 | 0.47979731 |
| 117 | RPS6KA6 | 0.47907673 |
| 118 | PIM2 | 0.47652328 |
| 119 | MARK2 | 0.46434441 |
| 120 | ICK | 0.42277679 |
| 121 | PDK1 | 0.42221334 |
| 122 | IGF1R | 0.41605002 |
| 123 | PIK3CA | 0.40805966 |
| 124 | BTK | 0.37974045 |
| 125 | EGFR | 0.37030940 |
| 126 | LIMK1 | 0.36957644 |
| 127 | CAMKK1 | 0.36944339 |
| 128 | IRAK1 | 0.36133136 |
| 129 | RET | 0.35960564 |
| 130 | IRAK2 | 0.35821973 |
| 131 | SGK2 | 0.35204471 |
| 132 | KIT | 0.32861352 |
| 133 | MAP2K1 | 0.32467668 |
| 134 | CSNK1G3 | 0.31948969 |
| 135 | MAP4K1 | 0.30180350 |
| 136 | MTOR | 0.29618286 |
| 137 | MAP3K6 | 0.29517961 |
| 138 | CSNK1A1L | 0.29419875 |
| 139 | CSNK1G2 | 0.28773011 |
| 140 | PRKD1 | 0.28348719 |
| 141 | ABL1 | 0.27947997 |
| 142 | MAP3K5 | 0.27519356 |
| 143 | ITK | 0.26819508 |
| 144 | CAMK4 | 0.26062883 |
| 145 | PDK3 | 0.25344122 |
| 146 | PDK4 | 0.25344122 |
| 147 | MYLK | 0.24841036 |
| 148 | IKBKB | 0.24589051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40361287 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.78110865 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54941066 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35973492 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26088040 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01234059 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74735735 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71607161 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69498448 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59230921 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52235185 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50491748 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42848750 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21403272 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14348622 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12631157 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.11433016 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98728761 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95171846 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91625318 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91209830 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89471169 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85512829 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84875787 |
| 25 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82162381 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77738140 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71047221 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70993470 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70210378 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68972140 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.64589886 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63205739 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61468481 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60811047 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55034378 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54593995 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.53220925 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52573960 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50594163 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.50118900 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.48133820 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.48039978 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44738895 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43484141 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40241136 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.37926379 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37056225 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.36125133 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30900767 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27503343 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.21720290 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 1.20355607 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19873983 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16192369 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.15948533 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14852219 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13560409 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12131628 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11710716 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 1.05538702 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04340444 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02910652 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02048643 |
| 64 | Malaria_Homo sapiens_hsa05144 | 1.00972697 |
| 65 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98447238 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98247798 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97619432 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94806030 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94211681 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93758100 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91822435 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86820740 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86649328 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85872076 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82544762 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.79369399 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77880486 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73306767 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72128595 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.70886854 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68593226 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68541814 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68288397 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68261700 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67525279 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66480858 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.66171836 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65657016 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65525515 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63502622 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63015591 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60044802 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57109092 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55429244 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55004951 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53663065 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51173280 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50363130 |
| 99 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50253609 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48597223 |
| 101 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45643078 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.43904566 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42883180 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.42236194 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40418938 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35807990 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35328948 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31377999 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27037112 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26237222 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.25599153 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22657402 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22622904 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19510895 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08699474 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03904026 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2234420 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2101854 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2054626 |
| 120 | Pertussis_Homo sapiens_hsa05133 | -0.2040859 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | -0.1976404 |
| 122 | Lysosome_Homo sapiens_hsa04142 | -0.1960832 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1846341 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1778820 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1673136 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1577945 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1485890 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | -0.1461795 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1362035 |
| 130 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1290535 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1186912 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1159763 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1088452 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1007675 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0927802 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0381402 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0066000 |

